Inflammatory myopathies: A new landscape, Joint Bone Spine. janv, vol.85, issue.1, pp.23-33, 2018. ,
Myositis mimics: how to recognize them. Current Opinion in Rheumatology, vol.26, pp.663-70, 2014. ,
Myopathies inflammatoires : diagnostic et classifications, La Presse Médicale. juill, vol.38, issue.7-8, pp.1141-63, 2009. ,
Incidence and prevalence of inflammatory myopathies: a systematic review, Rheumatology. janv, vol.54, issue.1, pp.50-63, 2015. ,
Inflammatory Muscle Diseases. Longo DL, éditeur, N Engl J Med, vol.372, issue.18, pp.1734-1781, 2015. ,
The clinical features, diagnosis and classification of dermatomyositis, Journal of Autoimmunity. févr, pp.122-129, 2014. ,
Laboratory Evaluation of the Inflammatory Myopathies, CLIN DIAGN LAB IMMUNOL, vol.2, p.9, 1995. ,
Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy: Combining MRI and Muscle Biopsy in IIM, Muscle Nerve. févr, vol.51, issue.2, pp.253-261, 2015. ,
Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies, Rheumatology. 27 sept, p.344, 2015. ,
A pattern-based approach to the interpretation of skeletal muscle biopsies, Modern Pathology. avr, vol.32, issue.4, pp.462-83, 2019. ,
Classification and management of adult inflammatory myopathies, The Lancet Neurology, vol.17, issue.9, pp.816-828, 2018. ,
Treatment in myositis, Nature Reviews Rheumatology. mai, vol.14, issue.5, pp.279-89, 2018. ,
Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study, Ann Rheum Dis. janv, vol.77, issue.1, pp.40-47, 2018. ,
Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort, Seminars in Arthritis and Rheumatism. déc, vol.45, issue.3, pp.301-309, 2015. ,
Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on, Autoimmunity and Cancer. Front Immunol. 21 août, vol.8, p.992, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02377507
Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyostis: A Systematic Review and Meta-Analysis ,
, PLoS ONE. 8 avr, vol.9, issue.4, p.94128, 2014.
Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort, Rheumatol Int. avr, vol.34, issue.4, pp.565-574, 2014. ,
Metaanalysis of the association of dermatomyositis and polymyositis with cancer, British Journal of Dermatology, vol.10, 2013. ,
The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis, Rheumatology. 1 avr, vol.58, issue.4, pp.650-655, 2019. ,
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort, Journal of Autoimmunity, vol.84, pp.55-64, 2017. ,
Hematological malignancy associated with polymyositis and dermatomyositis, Autoimmunity Reviews. juill, vol.11, issue.9, pp.615-635, 2012. ,
Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China, Oncol Lett ,
,
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study, The Lancet, vol.357, issue.9250, pp.96-100, 2001. ,
Spontaneous resolution of dermatomyositis associated with fallopian-tube carcinoma following staging surgery: A case report, Medicine. mars, vol.98, issue.10, p.14530, 2019. ,
Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study, Ann Rheum Dis. janv, vol.75, issue.1, pp.110-116, 2016. ,
Opportunistic infections in patients with idiopathic inflammatory myopathies, Int J Rheum Dis. févr, vol.21, issue.2, pp.487-96, 2018. ,
Infections in polymyositis and dermatomyositis: analysis of 192 cases, Rheumatology. 1 déc, vol.49, issue.12, pp.2429-2466, 2010. ,
Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score, Endocrine. avr, vol.52, issue.1, pp.86-92, 2016. ,
Classification of myositis, Nature Reviews Rheumatology. mai, vol.14, issue.5, pp.269-78, 2018. ,
New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter, Current Rheumatology Reports [Internet]. avr, vol.20, issue.4, 2018. ,
Myositis-specific autoantibodies: an important tool to support diagnosis of myositis, Journal of Internal Medicine. juill, vol.280, issue.1, pp.8-23, 2016. ,
Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies, Front Neurol. 8 mai, vol.10, p.438, 2019. ,
The association between Mi-2 antibodies and dermatomyositis, Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, vol.28, issue.7, pp.796-803, 1985. ,
Autoantibodies in myositis, Nature Reviews Rheumatology. mai, vol.14, issue.5, pp.290-302, 2018. ,
Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies: Study of 178 Cases and Guidelines for Diagnosis, Medicine. janv, vol.92, issue.1, pp.15-24, 2013. ,
Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease. Lung, vol.194, pp.733-740, 2016. ,
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1?: Antibodies to NXP-2 and TIF-1? in Cancer-Associated Dermatomyositis. Arthritis & Rheumatism, Based on Clinical Manifestations and Myositis-Specific Autoantibodies, vol.65, p.1528, 2013. ,
HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies, Arthritis Rheum, vol.54, issue.11, pp.3670-81, 2006. ,
Tumour TIF1 mutations and loss of heterozygosity related to cancerassociated myositis, Rheumatology. 1 févr, vol.57, issue.2, pp.388-96, 2018. ,
Association of the Autoimmune Disease Scleroderma with an Immunologic Response to, Cancer. Science. 10 janv, vol.343, issue.6167, pp.152-159, 2014. ,
Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab, Rheumatology. 1 juin, vol.55, issue.6, pp.991-1000, 2016. ,
Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis. Respiratory Investigation, vol.56, pp.464-72, 2018. ,
Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy, Arthritis Rheum. sept, vol.56, issue.9, pp.3125-3156, 2007. ,
Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy, Arthritis & Rheumatism. déc, vol.64, issue.12, pp.4087-93, 2012. ,
Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy, Arthritis & Rheumatism. juill, vol.63, issue.7, pp.1961-71, 2011. ,
In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy, Ann Rheum Dis. janv, vol.78, issue.1, pp.131-140, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02366089
Analysis of the Global RNA Expression Profiles of Skeletal Muscle Cells Treated with Statins, JAT, vol.12, issue.3, pp.121-152, 2005. ,
Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women, Arthritis Rheum. août, vol.60, issue.8, pp.2499-504, 2009. ,
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera, Journal of Immunological Methods. juin, vol.433, pp.1-5, 2016. ,
Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies. Front Immunol, vol.10, p.848, 2019. ,
Standardisation of myositisspecific antibodies: where are we today?, Ann Rheum Dis. 3 août, 2019. ,
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy, Clinical Reviews in Allergy & Immunology. févr, vol.52, issue.1, pp.1-19, 2017. ,
A Negative Antinuclear Antibody Does Not Indicate Autoantibody Negativity in Myositis: Role of Anticytoplasmic Antibody as a Screening Test for Antisynthetase Syndrome, J Rheumatol. févr, vol.44, issue.2, pp.223-232, 2017. ,
Detection of myositis-specific antibodies, Ann Rheum Dis. janv, vol.78, issue.1, pp.7-7, 2019. ,
Response to: 'Detection of myositisspecific antibodies' by Vulsteke et al, Ann Rheum Dis. janv, vol.78, issue.1, pp.8-8, 2019. ,
Less specific myositis autoantibodies?, Annals of the Rheumatic Diseases. 1 août, vol.60, issue.8, pp.810-810, 2001. ,
The clinical phenotype associated with myositis-specific and associated autoantibodies: A metaanalysis revisiting the so-called antisynthetase syndrome, Autoimmunity Reviews. sept, vol.13, issue.9, pp.883-91, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02046821
Anti-glomerular basement membrane disease: an update on subgroups, pathogenesis and therapies, Nephrology Dialysis Transplantation ,
,
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients, Kidney International. sept, vol.92, issue.3, pp.693-702, 2017. ,
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies, Thromb Haemost, vol.90, issue.07, pp.108-123, 2003. ,
The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Expert Review of Clinical Immunology, vol.11, pp.1255-63, 2015. ,
Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroidstimulating hormone level and advanced tumor stage of papillary thyroid cancer, Endocrine. août, vol.46, issue.3, pp.554-60, 2014. ,
Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis, Annals of the Rheumatic Diseases. 1 févr, vol.61, issue.2, pp.121-128, 2002. ,
New insights in myositis-specific autoantibodies: Current Opinion in Rheumatology, vol.30, pp.614-636, 2018. ,
Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody, Seminars in Arthritis and Rheumatism. juin, vol.41, issue.6, pp.890-899, 2012. ,
Coexistence of two antisynthetases in a patient with the antisynthetase syndrome, Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, vol.39, issue.4, pp.692-697, 1996. ,
Characterization of Dermatomyositis with Coexistence of Anti-Jo-1 and Anti-SRP Antibodies, Intern Med, vol.51, issue.7, pp.799-802, 2012. ,
An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis, Clin Rheumatol. juill, vol.29, issue.7, pp.811-815, 2010. ,
High Frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis, Rheumatology International. juill, vol.32, issue.7, pp.2057-61, 2012. ,
Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report, Disponible sur, vol.2, 2018. ,
Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients, Journal of Autoimmunity. juill, vol.101, pp.48-55, 2019. ,
Combining immunofluorescence with immunoblot assay improves the specificity of autoantibody testing for myositis, Rheumatology. 1 juill, vol.58, issue.7, pp.1239-1283, 2019. ,
Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a chinese patient cohort with myositis: Medicine, vol.97, p.13236, 2018. ,
Correspondence to 'Standardisation of myositisspecific antibodies: where are we today?' by Mahler et al, Ann Rheum Dis. 6 sept, pp.2019-216217, 2019. ,
Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study, Immunol Res. juin, vol.64, issue.3, pp.677-86, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01821459
Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective, Ann Rheum Dis. juill, vol.78, issue.7, pp.879-89, 2019. ,
Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: A one-year retrospective study, Autoimmunity. 17 févr, vol.51, issue.2, pp.89-95, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01881121
Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients. Seminars in Arthritis and Rheumatism, vol.49, pp.283-290, 2019. ,
Clinical features of anti-TIF1-antibodypositive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-or anti-Mi-2 autoantibodies, Rheumatology. 1 août, vol.51, issue.8, pp.1508-1521, 2012. ,
Diagnostic performance of a commercial immunoblot assay for myositis antibody testing, Pathology. juin, vol.48, issue.4, pp.363-369, 2016. ,
, Diagnostic différentiel des myopathies inflammatoires idiopathiques, vol.2
, Myopathies associées aux endocrinopathies (dysthyroïdie, hypercorticisme
, Myosite focale
, Myopathies toxiques : alcool ou médicament (corticoïde, colchicine, hydroxychloroquine, statine, antirétroviraux
, Myopathies à bâtonnet acquises (VIH, gammapathie monoclonale)
, Myosite de dénervation (radiculopathie, maladie du motoneurone)
, Traumatisme, vol.56
, Annexe 3 : Répartition des spécialités dans les prescriptions des DOT-myosites
, Répartition des patients avec un DOT positif, négatif ou douteux selon le sexe Annexe 5 : Age des patients selon l, Annexe, vol.4
, Annexe 6 : Répartition des sexes selon les ASM